Management of renal hyperparathyroidism (Q33983813)

30 July 2017

1 reference

title

Management of renal hyperparathyroidism (English)

1 reference

30 July 2017

1 reference

Tominaga Y

1

1 reference

30 July 2017

publication date

1 June 2000

1 reference

Biomedicine and Pharmacotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

54 Suppl 1

1 reference

30 July 2017

page(s)

25s-31s

1 reference

A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure: Rapid Communication

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Cloning and characterization of an extracellular Ca(2 )-sensing receptor from bovine parathyroid

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Medical and surgical aspects of parathyroidectomy

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Effect of 22-oxacalcitriol on hyperparathyroidism of dialysis patients: results of a preliminary study

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Surgical significance of supernumerary parathyroid glands in renal hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

The hyperparathyroidism of chronic renal failure: A disorder of growth

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Short-Term Inhibition of Parathyroid Hormone Secretion by a Calcium-Receptor Agonist in Patients with Primary Hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissue

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Mechanism of parathyroid tumourigenesis in uraemia

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Molecular genetics of hyperparathyroid disease.

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Surgical treatment of renal hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Renal transplantation and secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

Prevention of renal osteodystrophy in peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016/S0753-3322(00)80007-4

7 January 2021

10.1016/S0753-3322(00)80007-4

Identifiers

DOI

1 reference

30 July 2017

1 reference